🔁 23rd European Society for Vector Ecology (ESOVE) Conference was held in Montpellier from 14-17 October 2024. This year's theme, One Health in Action, highlighted exciting new developments in bridging vertebrate and plant health communities. Angelique Porciani from IRD, Montpellier, presented promising results on the benefits of using Long-Acting Injectable (LAI) ivermectin in livestock, leveraging Medincell's BEPO® technology, to combat malaria transmission in areas where humans and livestock are in close proximity. 🌍 This breakthrough, developed through a strong consortium with IRD, CIRDES, IRSS Burkina Faso, Justus Liebig University Giessen, and Medincell, is another step toward sustainable and impactful vector control solutions. #OneHealth #ESOVE2024 #VectorControl #GlobalHealth #MalariaControl #LAI #Medincell #Sustainability
The 23rd European Society for Vector Ecology (ESOVE) Conference was held in Montpellier, France from 14 to 17 October 2024. This year theme was: One Health in action: supporting and accelerating the bridging of the vertebrate and plant health communities In this context, several presentations were made to highlight the benefits of the Long-Acting Injectable (LAI) ivermectin as a new complementary tool to combat malaria transmission. Angélique Porciani from IRD in Montpellier, France, made an oral presentation showing promising results regarding the expected benefits of injecting cattle with an ivermectin LAI formulation using Medincell BEPO technology. Angélique Porciani explained: « The use of a long-acting formulation of ivermectin increase the duration of the lethal effect on malaria vector population and give a new tool to control residual malaria transmission in areas where there is close vicinity between livestock and human. The environmental drawbacks could be managed with the cooperation of the local breeders and stakeholders, even if complementary studies are needed to accurately assess the effect and the fate of ivermectin in soil. Our study, embedding comprehensive modelling, an innovative formulation of Ivermectin and ecotoxicological insights promises a new aspect of sustainable vector control and demonstrate that One Health in vector control could be a reality. » .” This formulation of ivermectin has been successfully developed thanks to a strong consortium between IRD, CIRDES, IRSS Burkina Faso, JUSTUS LIEBIG UNIVERSITAT GIESSEN and Medincell. #IRDMontpellier #UniverstitéMontpellier #MiVEGEC #CIRDES #IRSSBurkinaFaso #JustusLiebigUniversitätGiessen #BarcelonaInstituteforGlobalHealth(ISGlobal) #Medincell